ProQR Therapeutics (PRQR) Assets (2013 - 2025)

ProQR Therapeutics' Assets history runs 13 years deep, the most recent figure standing at $131.3 million for Q4 2025.

• In Q4 2025, Assets fell 26.87% year-over-year to $131.3 million; the TTM figure through Dec 2025 stood at $131.3 million (down 26.87% YoY), while the FY2025 annual figure was $131.3 million, down 26.87% from the prior year.
• Assets came in at $131.3 million for Q4 2025 at ProQR Therapeutics, down from $179.5 million in the prior quarter.
• In the past five years, Assets ranged from a high of $110.5 billion in Q1 2021 to a low of $122.7 million in Q3 2022.
• A 5-year average of $8.1 billion and a median of $177.1 million in 2022 frame the typical range for Assets.
• Across the five-year window, Assets soared 96487.99% in 2021 and tumbled 99.81% in 2022, its largest moves.
• ProQR Therapeutics' Assets stood at $239.8 million in 2021, then fell by 27.1% to $174.8 million in 2022, then fell by 15.12% to $148.4 million in 2023, then gained by 20.98% to $179.5 million in 2024, then fell by 26.87% to $131.3 million in 2025.
• According to Business Quant data, Assets over the past three periods registered $131.3 million, $179.5 million, and $148.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison